FOX News logo
Boston Herald logo
CBS News logo
4 articles
·1M

FDA Approves First Blood Test for Alzheimer’s Diagnosis

The FDA has approved a blood test to help diagnose Alzheimer’s in patients over 55, marking a milestone in cognitive health.

Overview

A summary of the key points of this story verified across multiple sources.

The FDA has endorsed the Lumipulse blood test from Fujirebio Diagnostics, Inc. for diagnosing Alzheimer’s disease in individuals over 55 with cognitive decline. This first-ever blood test identifies beta-amyloid plaques linked to Alzheimer’s, offering a less invasive and more cost-effective alternative to costly PET scans and spinal fluid tests. This approval supports early intervention with new treatments like Leqembi and Kisunla, which can modestly slow disease progression. Dr. Michelle Tarver from the FDA emphasized the test’s potential for improving patient access to timely diagnosis and appropriate treatment.

Content generated by AI—learn more or report issue.

Pano Newsletter

Get both sides in 5 minutes with our daily newsletter.

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

  • The FDA has cleared the first blood test for Alzheimer’s disease, making early diagnosis more accessible and potentially beneficial for patient treatment.

Articles (4)

Compare how different news outlets are covering this story.

LeftCenterRight
CBS News
Associated Press
Boston Herald
FOX News

FAQ

Dig deeper on this story with frequently asked questions.

The blood test approved by the FDA is called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio.

The Lumipulse G blood test was developed by Fujirebio Diagnostics, Inc.

The test is intended for adults aged 55 and older who are showing signs of cognitive decline.

The test offers a less invasive alternative to PET scans and spinal fluid tests, providing a more accessible and potentially cost-effective option for diagnosing Alzheimer's.

History

See how this story has evolved over time.

  • This story does not have any previous versions.